In an interview with Targeted Oncology, Sarbajit Mukherjee, MD, gastrointestinal (GI) medical oncologist at Baptist Health ...

The biopharmaceutical sector is transitioning from reactive off-line quality control to a proactive quality by design (QbD) framework. Process analytical technology (PAT) enables this shift through ...

Rove beetles cloak themselves in ant pheromones to sneak into the insects’ nests for protection. But in an odd catch-22, that ...

From penetrating solid tumors to new success rates for de novo design, the next wave of antibody therapies aims to transform the clinic.

A clinical-stage biotechnology company developing precision drug conjugates designed to expand the range of targets ...

Discover the potential of lab-made antibodies in targeting drug-resistant bacteria and fighting hospital-acquired infections.

Reading Time: 4 minutes“Understanding the position of the other side helps open dialogue that can lead to peace. After all, ...